Use App
Trending
News
Earnings
All
DIA
0.26%
SPY
1.15%
QQQ
2.47%
Trending
SNDK
13.11%
QS
16.67%
BFLY
57.18%
CIFR
11.46%
DJT
4.14%
ACN
17.64%
BTQ
8.49%
BE
15.66%
WBD
0.15%
INTC
10.71%
SNDK
13.11%
QS
16.67%
BFLY
57.18%
CIFR
11.46%
DJT
4.14%
ACN
17.64%
BTQ
8.49%
BE
15.66%
WBD
0.15%
INTC
10.71%
home
Symbol
IBRX
Exchange:
NASDAQ
·
Updated 05:54 PM EDT
IBRX
ImmunityBio Inc
$7.30
$0.37
(5.29%)
Today
·
Closed $7.36
$0.06
(0.81%)
After Hours
2
9
,
2
2
8
News
·
Nasdaq, S&P 500 Futures Gain Ahead Of Kevin Warsh’s First Fed Meeting: Why SPCX, ASTS, INTC, MU, SOFI, SMCI Are In Focus
2
9
,
2
2
8
Mkt Cap
$7.32B
Vol
14.33M
Full Chart
Fundamentals
Mkt Cap
$7.32B
Volume
-
52W High
$12.43
52W Low
$1.95
PE Ratio
-8.18
Avg. Volume
14.83M
EPS (Annual)
-$0.382
P/B
-8.41
Rev/Employee
$163,947.90
Earnings
-
Feed
News
Sentiment
Fundamentals
Info
Advertisement
|
Remove ads.
Latest IBRX News
View
Nasdaq, S&P 500 Futures Gain Ahead Of Kevin Warsh’s First Fed Meeting: Why SPCX, ASTS, INTC, MU, SOFI, SMCI Are In Focus
Stocktwits
The Multi-Billion-Dollar Race to Defeat Glioblastoma: Why Investors Are Watching One of Oncology's Most Challenging Frontiers
24-7 Market News
ImmunityBio Presents New Clinical and Comparative Data Across Lung and Bladder Cancer at ASCO 2026
Business Wire
Loading...
Top Discussions
top
active
trending
Advertisement
|
Remove ads.
Advertisement
|
Remove ads.
Watchlist
Trending
News
Explore
Community
Profile